Laurent Misery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laurent Misery has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
A Claudy
INSERM U 346 and Department of Dermatology, Edouard Herriot Hospital, Place d’Arsonval, 69437 Lyon cedex 03, France
14 shared publicationsD Schmitt
INSERM U 346 and Department of Dermatology, Edouard Herriot Hospital, Place d’Arsonval, 69437 Lyon cedex 03, France
6 shared publicationsM Faure
Department of Dermatology and INSERM U346 ‘Human Skin and Immunity’, Hôpital Edouard Herriot, Lyon
6 shared publicationsA. Claudy
3 shared publicationsJ Kanitakis
INSERM U 346 and Department of Dermatology, Edouard Herriot Hospital, Place d’Arsonval, 69437 Lyon cedex 03, France
3 shared publications- J. Viac
INSERM U346, Clinique Dermatologique, Hôpital E. Herriot, 69437 Lyon 03, France
3 shared publications
Latest Publications
- 1 September 2004
- Published by Wiley in Experimental Dermatology
- Vol. 13 (9) , 578-579
Co‐culture of neurones with Merkel cells and keratinocytes
- 1 September 2004
- Published by Wiley in Experimental Dermatology
- Vol. 13 (9) , 578-579
Co‐culture of neurones with Merkel cells and keratinocytes
- 1 May 2001
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 15 (3) , 238-241
Modulation of substance P and somatostatin receptors in cutaneous lymphocytic inflammatory and tumoral infiltrates
Background: The expression of receptors for neuropeptides in the skin is modified in skin diseases.Objective: We studied the cutaneous expression of substance P (SP) and somatostatin (SOM) receptors (SPR and SSTR, respectively) in skin affected by cutaneous inflammatory or tumoral T‐cell infiltrates because these two neuropeptides are the ones most involved in inflammation.Methods: We revealed expression of these receptors using a binding in situ technique that gave highly specific results. Skin biopsies were incubated with biotinylated neuropeptides (SP or SOM).Results: In normal skin, SSTR were observed on blood vessels, smooth muscle fibres and sweat glands. SSTR expression was modified only when expressed by keratinocytes in Ofuji papuloerythroderma and by plasmocytes in plasmocytoma. SPR distribution was not modified in subjects with atopic dermatitis or lupus. The expression of SPR in the epidermis was diminished in Ofuji papuloerythroderma and parapsoriasis and absent in mycosis fungoides.Conclusions: These results suggest that malignant lymphocytic infiltrates can inhibit SPR expression on keratinocytes.
- 1 May 2001
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 15 (3) , 238-241
Modulation of substance P and somatostatin receptors in cutaneous lymphocytic inflammatory and tumoral infiltrates
Background: The expression of receptors for neuropeptides in the skin is modified in skin diseases.Objective: We studied the cutaneous expression of substance P (SP) and somatostatin (SOM) receptors (SPR and SSTR, respectively) in skin affected by cutaneous inflammatory or tumoral T‐cell infiltrates because these two neuropeptides are the ones most involved in inflammation.Methods: We revealed expression of these receptors using a binding in situ technique that gave highly specific results. Skin biopsies were incubated with biotinylated neuropeptides (SP or SOM).Results: In normal skin, SSTR were observed on blood vessels, smooth muscle fibres and sweat glands. SSTR expression was modified only when expressed by keratinocytes in Ofuji papuloerythroderma and by plasmocytes in plasmocytoma. SPR distribution was not modified in subjects with atopic dermatitis or lupus. The expression of SPR in the epidermis was diminished in Ofuji papuloerythroderma and parapsoriasis and absent in mycosis fungoides.Conclusions: These results suggest that malignant lymphocytic infiltrates can inhibit SPR expression on keratinocytes.
- 1 December 1999
- Vol. 150 (8) , 591-3
[Motivations of requests for human immunodeficiency virus (HIV) infection screening at the Centers of Information and Anonymous and Free-of-Charge Screening. Study of 891 cases].
In France, human immunodeficiency virus (HIV) testing is usually performed in centers for information and anonymous cost-free detection (Centres d'Information et de Dépistage Anonyme et Gratuit, CIDAG). In this work, we studied the reasons people ask for HIV testing at the CIDAG in Lyons. Eight hundred and ninety one people were asked to give their reasons. The response ratio was 85% and the sex-ratio 1:1. Seventy-five percent of the people were single. The main motivation was the desire to begin a relationship with another person without using condoms. Nonetheless, we were impressed by the high level of high-risk behaviors. To our knowledge, this is the first study about motivations of outpatients at the CIDAG.
- 1 December 1999
- Vol. 150 (8) , 591-3
[Motivations of requests for human immunodeficiency virus (HIV) infection screening at the Centers of Information and Anonymous and Free-of-Charge Screening. Study of 891 cases].
In France, human immunodeficiency virus (HIV) testing is usually performed in centers for information and anonymous cost-free detection (Centres d'Information et de Dépistage Anonyme et Gratuit, CIDAG). In this work, we studied the reasons people ask for HIV testing at the CIDAG in Lyons. Eight hundred and ninety one people were asked to give their reasons. The response ratio was 85% and the sex-ratio 1:1. Seventy-five percent of the people were single. The main motivation was the desire to begin a relationship with another person without using condoms. Nonetheless, we were impressed by the high level of high-risk behaviors. To our knowledge, this is the first study about motivations of outpatients at the CIDAG.
- 1 August 1999
- Vol. 8 (4) , 267-73
Human normal dermal fibroblasts express somatostatin receptors.
The hormone/neuropeptide somatostatin (SOM) exerts multiple functions in the central nervous system, the immune system, the hypothalamo-pituitary axis, the gastrointestinal tract, and the pancreas. Endogenous SOM occurs in 2 biologically active forms, with 14 or 28 amino acids. Five subtypes of SOM receptors have been cloned. SOM is present in human skin. We have investigated the expression of SOM receptors on human dermal normal fibroblasts. Biotinyl-SOM allowed the visualization of SOM receptors on human dermal fibroblasts. Radioligand binding studies with (3-[125I]iodotyrosyl11)-SOM-14 were performed on these cells and the effect of SOM-14 on the DNA synthesis by fibroblasts was evaluated by measuring [3H]-methyl thymidine incorporation. Saturation curve, and Scatchard plot showed a homogeneous class of receptors with a Bmax of 0.055 +/- 0.023 nM and KD of 2.0 +/- 0.4 nM (values: mean +/- SEM). Fibroblasts expressed 3,317 +/- 1,385 binding sites per cell. Competitive displacement experiments showed that SOM-14 IC50 was 69.3 +/- 4.5 nM (mean +/- SEM), for SOM-28 33.2 +/- 6.0 nM and for octreotide 36.5 +/- 3.3 nM. The KI values calculated from these IC50 were, respectively: 62.4 +/- 4.1 nM; 29.9 +/- 5.4 nM; 32.9 +/- 2.9 nM. We conclude that subtype 2 or 3 SOM receptors is present on human normal dermal fibroblasts. A weak effect of SOM-14 on DNA synthesis was observed with SOM concentrations of 10(-7) and 10(-6) M.
- 1 August 1999
- Vol. 8 (4) , 267-73
Human normal dermal fibroblasts express somatostatin receptors.
The hormone/neuropeptide somatostatin (SOM) exerts multiple functions in the central nervous system, the immune system, the hypothalamo-pituitary axis, the gastrointestinal tract, and the pancreas. Endogenous SOM occurs in 2 biologically active forms, with 14 or 28 amino acids. Five subtypes of SOM receptors have been cloned. SOM is present in human skin. We have investigated the expression of SOM receptors on human dermal normal fibroblasts. Biotinyl-SOM allowed the visualization of SOM receptors on human dermal fibroblasts. Radioligand binding studies with (3-[125I]iodotyrosyl11)-SOM-14 were performed on these cells and the effect of SOM-14 on the DNA synthesis by fibroblasts was evaluated by measuring [3H]-methyl thymidine incorporation. Saturation curve, and Scatchard plot showed a homogeneous class of receptors with a Bmax of 0.055 +/- 0.023 nM and KD of 2.0 +/- 0.4 nM (values: mean +/- SEM). Fibroblasts expressed 3,317 +/- 1,385 binding sites per cell. Competitive displacement experiments showed that SOM-14 IC50 was 69.3 +/- 4.5 nM (mean +/- SEM), for SOM-28 33.2 +/- 6.0 nM and for octreotide 36.5 +/- 3.3 nM. The KI values calculated from these IC50 were, respectively: 62.4 +/- 4.1 nM; 29.9 +/- 5.4 nM; 32.9 +/- 2.9 nM. We conclude that subtype 2 or 3 SOM receptors is present on human normal dermal fibroblasts. A weak effect of SOM-14 on DNA synthesis was observed with SOM concentrations of 10(-7) and 10(-6) M.
- 1 July 1999
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 117 (1) , 177-182
Presence of circulating abnormal CD34+ progenitors in adult Langerhans cell histiocytosis
Langerhans cell histiocytosis (LCH) is related to the proliferation of cells, which are similar to Langerhans cells (LC) but possess many abnormal characteristics. Lesions are widespread and this fact suggests that LCH cells or their precursors are present in the blood of patients. In five adult patients, we have isolated and cultured CD34+ blood progenitors of dendritic cells. We studied their phenotype by flow cytometry and their functional properties in mixed culture with heterologous lymphocytes and with autologous lymphocytes in the presence of tri-nitro-phenyl antigen (TNP). The amount of CD34+ precursors was dramatically higher than controls but a high mortality occurred during the in vitro differentiation. The phenotype of surviving cells was similar to LC phenotype (CD1a+, CD83+, Lag+) but some of them expressed CD2. These cells were able to induce T cell proliferation in mixed culture. They could not initiate primary response to TNP, except in a patient treated with thalidomide. In our hands, these CD34+ cells may be precursors of LCH cells.
- 1 July 1999
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 117 (1) , 177-182
Presence of circulating abnormal CD34+ progenitors in adult Langerhans cell histiocytosis
Langerhans cell histiocytosis (LCH) is related to the proliferation of cells, which are similar to Langerhans cells (LC) but possess many abnormal characteristics. Lesions are widespread and this fact suggests that LCH cells or their precursors are present in the blood of patients. In five adult patients, we have isolated and cultured CD34+ blood progenitors of dendritic cells. We studied their phenotype by flow cytometry and their functional properties in mixed culture with heterologous lymphocytes and with autologous lymphocytes in the presence of tri-nitro-phenyl antigen (TNP). The amount of CD34+ precursors was dramatically higher than controls but a high mortality occurred during the in vitro differentiation. The phenotype of surviving cells was similar to LC phenotype (CD1a+, CD83+, Lag+) but some of them expressed CD2. These cells were able to induce T cell proliferation in mixed culture. They could not initiate primary response to TNP, except in a patient treated with thalidomide. In our hands, these CD34+ cells may be precursors of LCH cells.
- 1 September 1998
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 11, S301
Merkel cell carcinoma and chronic lymphocytic leukemia
- 1 September 1998
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 11, S301
Merkel cell carcinoma and chronic lymphocytic leukemia
- 1 April 1998
- Vol. 125 (4) , 264-7
[Epidermolysis bullosa acquisita and hepatitis C].
Epidermolysis bullosa acquisita is a bullous dermatosis. Its etiology remains unknown and the efficacy of its treatment is low. We report the first association between epidermolysis bullosa acquisita, chronic hepatitis C and cryoglobulinemia, healing with interferon alpha and ribavirine. We suggest a role for hepatitis C virus in the pathogenesis of epidermolysis bullosa acquisita. We suppose a synthesis of autoimmune antibodies in a dysimmune environment. Interferon alpha and ribavirine might be a new therapeutic avenue but further studies are necessary to confirm it.
- 1 April 1998
- Vol. 125 (4) , 264-7
[Epidermolysis bullosa acquisita and hepatitis C].
Epidermolysis bullosa acquisita is a bullous dermatosis. Its etiology remains unknown and the efficacy of its treatment is low. We report the first association between epidermolysis bullosa acquisita, chronic hepatitis C and cryoglobulinemia, healing with interferon alpha and ribavirine. We suggest a role for hepatitis C virus in the pathogenesis of epidermolysis bullosa acquisita. We suppose a synthesis of autoimmune antibodies in a dysimmune environment. Interferon alpha and ribavirine might be a new therapeutic avenue but further studies are necessary to confirm it.
- 1 September 1997
- Vol. 137 (3) , 376-80
Presence of somatostatin in normal human epidermis.
Somatostatin (SOM) is a ubiquitous peptide which is responsible for the inhibition of numerous biological functions. SOM is described as an antiproliferative molecule and an inhibitor of exocrine or endocrine secretion from a variety of tissues, including pancreas, gastrointestinal tract, central and peripheral nervous system. Mediation of SOM effects can be indirect or direct, respectively, through other molecules or receptors on target cells. We have searched for the presence of SOM in the epidermis using immunofluorescence, confocal laser scanning microscopy, radioimmunoassay, and chromatography. Immunofluorescence and confocal laser scanning microscopy studies were performed using rabbit antiserum anti-SOM and mouse monoclonal antibody directed to CD1a Langerhans cell (LC) marker disclosed with fluorescein or tetramethylrhodamine isothiocyanate conjugates. SOM was extracted from whole skin or epidermal cell suspension or LC-enriched suspensions and analysed by radioimmunoassay. We used an antiserum which was reactive for the 6-11 portion of native SOM. Chromatographic columns were performed on extracts from whole skin. The epidermis was SOM immunoreactive. LC were immunoreactive for SOM and the staining was membranous. SOM was extracted from the whole skin at about 0.13 +/- 0.02 fmol/mg of tissue (mean +/- SEM). The SOM concentration in epidermal cell suspensions was 1.5 +/- 0.9 fmol/10(6) cells. Data obtained with LC-enriched suspensions showed large variations between donors. Extracts from skin showed one peak with an elution profile like that of 14 amino acid SOM. This study demonstrates that 14 amino acid SOM is expressed in normal human epidermis.
- 1 September 1997
- Vol. 137 (3) , 376-80
Presence of somatostatin in normal human epidermis.
Somatostatin (SOM) is a ubiquitous peptide which is responsible for the inhibition of numerous biological functions. SOM is described as an antiproliferative molecule and an inhibitor of exocrine or endocrine secretion from a variety of tissues, including pancreas, gastrointestinal tract, central and peripheral nervous system. Mediation of SOM effects can be indirect or direct, respectively, through other molecules or receptors on target cells. We have searched for the presence of SOM in the epidermis using immunofluorescence, confocal laser scanning microscopy, radioimmunoassay, and chromatography. Immunofluorescence and confocal laser scanning microscopy studies were performed using rabbit antiserum anti-SOM and mouse monoclonal antibody directed to CD1a Langerhans cell (LC) marker disclosed with fluorescein or tetramethylrhodamine isothiocyanate conjugates. SOM was extracted from whole skin or epidermal cell suspension or LC-enriched suspensions and analysed by radioimmunoassay. We used an antiserum which was reactive for the 6-11 portion of native SOM. Chromatographic columns were performed on extracts from whole skin. The epidermis was SOM immunoreactive. LC were immunoreactive for SOM and the staining was membranous. SOM was extracted from the whole skin at about 0.13 +/- 0.02 fmol/mg of tissue (mean +/- SEM). The SOM concentration in epidermal cell suspensions was 1.5 +/- 0.9 fmol/10(6) cells. Data obtained with LC-enriched suspensions showed large variations between donors. Extracts from skin showed one peak with an elution profile like that of 14 amino acid SOM. This study demonstrates that 14 amino acid SOM is expressed in normal human epidermis.
- 1 December 1996
- Vol. 44 (10) , 829
[Skin and neuromediators].
- 1 March 1996
- Vol. 134 (3) , 604-5
Follow-up of circulating ICAM-1 in malignant melanoma: correlation with the clinical course of the disease.
- 1 March 1996
- Vol. 134 (3) , 604-5
Follow-up of circulating ICAM-1 in malignant melanoma: correlation with the clinical course of the disease.